Less time. Less contact. Less risk.

Unlike the 112-year-old TB skin test, which requires two or more visits, the TB blood test requires only one visit. That means at least a 50% reduction in contact to promote greater safety for staff and patients during COVID-19.

It also means employees spend less time away from their jobs, giving them more time to focus on patient care.

The pandemic has put immunocompromised patients and employees at even more risk, especially as they seek routine care and lab testing. That’s why, for new-hire TB screening and routine employee testing, it’s important to know you’re choosing a safer option.

T-SPOT.TB from Quest Diagnostics is the only TB blood test without a warning in the immunocompromised population, making it well-suited for all employees, including those with weakened immune systems.¹

The TB blood test is not only a safer option than the TB skin test, but it can also be more economical due to:

• Less risk of unnecessary follow-up testing because of false-positive results
• Less risk of unnecessary repeat testing—the TB blood test has demonstrated lower false-positive rates than the skin test in BCG-vaccinated individuals²
• Less staff time to administer
• Less time away from work for employees being tested